A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/517 (2006.01) A61K 31/35 (2006.01) A61K 31/42 (2006.01) A61K 31/538 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2495799
The present invention relates to the treatment of hypertension and type 2 diabetes, Metabolic Syndrome or a pre-diabetic state, by the administration of a therapeutically effective amount of a combination of a dual PPAR.alpha./.gamma. agonist and an Angiotensin II type I receptor antagonist, including pharmaceutically acceptable salts and solvates of said active ingredients.
L'invention concerne le traitement de l'hypertension et du diabète de type 2, du syndrome métabolique ou d'un état pré-diabétique, par administration d'une dose thérapeutiquement efficace d'une combinaison d'un double agoniste de PPAR .alpha./.beta. et d'un récepteur de type I d'angiotensine II, comprenant des sels et des solvates pharmaceutiquement acceptables desdits principes actifs.
Fox Jonathan C.
Mercuri Michele
Waldstreicher Joanne
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
LandOfFree
Combination therapy using a dual ppar alpha/gamma agonist... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy using a dual ppar alpha/gamma agonist..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy using a dual ppar alpha/gamma agonist... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1452405